Company Filing History:
1 out of 16 
1 out of 2,488 
1 out of 1,157 
Years Active: 2010-2025
Title: Innovations and Contributions of Vidal F De La Cruz, Jr.
Introduction
Vidal F De La Cruz, Jr. is a notable inventor based in Phoenixville, PA, with a significant contribution to the field of pharmaceuticals. He holds a total of four patents, showcasing his innovative approach to addressing complex medical challenges. His work primarily focuses on immune response suppression and cardiac dysfunction treatment.
Latest Patents
Among his latest patents, one includes "Compounds and methods for suppressing an immune response to substances containing polyethylene glycol." This invention provides compounds, compositions, and methods aimed at mitigating immune responses associated with polyethylene glycol (PEG). Another significant patent is titled "Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as cardiac-derived myocardial depressant factor." This patent encompasses a pharmaceutical composition that includes a therapeutically effective amount of at least one anti-MIF antibody, along with various other anti-bodies and carriers. These innovations are crucial for treating cardiac dysfunction and improving patient outcomes following acute myocardial infarction.
Career Highlights
Vidal has worked with prominent companies such as Cytokine Pharmasciences, Inc. and Baxter International Inc., where he has applied his expertise in developing groundbreaking medical solutions. His career reflects a commitment to advancing healthcare through innovative research and development.
Collaborations
Throughout his career, Vidal has collaborated with talented individuals, including Thais Motria Sielecki-Dzurdz and Ruben Zamora. These partnerships have contributed to the success of his projects and the advancement of medical science.
Conclusion
Vidal F De La Cruz, Jr. exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations highlight his dedication to improving health outcomes through scientific advancements. His contributions continue to impact the field positively.